Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparative efficacy and safety of biologics in moderate to severe plaque psoriasis: a multiple‐treatments meta‐analysis
Shanshan Xu, Xing Gao, Jixiang Deng, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2020) Vol. 19, Iss. 1, pp. 47-56
Closed Access | Times Cited: 22

Showing 22 citing articles:

Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
É. Sbidian, Anna Chaimani, I. García‐Doval, et al.
Cochrane library (2022) Vol. 2022, Iss. 8
Open Access | Times Cited: 106
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
É. Sbidian, Anna Chaimani, Robin Guelimi, et al.
Cochrane library (2023) Vol. 2023, Iss. 7
Open Access | Times Cited: 89
ACSL4 is overexpressed in psoriasis and enhances inflammatory responses by activating ferroptosis
Le Liu, Xiao-xiao Kang
Biochemical and Biophysical Research Communications (2022) Vol. 623, pp. 1-8
Closed Access | Times Cited: 25
Comparing Meta-Analyses with ChatGPT in the Evaluation of the Effectiveness and Tolerance of Systemic Therapies in Moderate-to-Severe Plaque Psoriasis
Xuân‐Lan Lam Hoai, Thierry Simonart
Journal of Clinical Medicine (2023) Vol. 12, Iss. 16, pp. 5410-5410
Open Access | Times Cited: 13
Eczematized psoriasis – a frequent but often neglected variant of plaque psoriasis
Felix Lauffer, Kilian Eyerich
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2023) Vol. 21, Iss. 5, pp. 445-453
Open Access | Times Cited: 12
Direct Comparison of Real-world Effectiveness of Biologics for Psoriasis using Absolute and Relative Psoriasis Area and Severity Index Scores in a Prospective Multicentre Cohort
M. E. van Muijen, Sarah E. Thomas, Hans Groenewoud, et al.
Acta Dermato Venereologica (2022) Vol. 102, pp. adv00712-adv00712
Open Access | Times Cited: 13
Association of Interleukin-17 Inhibitors With Hypertension in Patients With Autoimmune Diseases: A Systematic Review and Meta-analysis on Randomized Controlled Trials
Kexin Jiang, Yuheng Jia, Li Chen, et al.
Journal of Cardiovascular Pharmacology (2024) Vol. 83, Iss. 6, pp. 557-564
Closed Access | Times Cited: 2
Overlapping network meta‐analyses on psoriasis systemic treatments, an overview: quantity does not make quality
Robin Guelimi, Sivem Afach, Jean-Philippe Régnaux, et al.
British Journal of Dermatology (2021) Vol. 187, Iss. 1, pp. 29-41
Open Access | Times Cited: 15
Occurrence of adverse events associated with the initiation of methotrexate and biologics for the treatment of psoriasis in routine clinical practice
Faizan Mazhar, Åsa Krantz, Lovisa Schalin, et al.
Journal of Dermatological Treatment (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 4
Extracellular Vesicles in the Skin Microenvironment: Emerging Roles as Biomarkers and Therapeutic Tools in Dermatologic Health and Disease
Joseph P. Flemming, Peter J. Wermuth, Mỹ G. Mahoney
Journal of Investigative Dermatology (2023) Vol. 144, Iss. 2, pp. 225-233
Closed Access | Times Cited: 4
Comparative short-term risks of infection and serious infection in patients receiving biologic and small-molecule therapies for psoriasis and psoriatic arthritis: a systemic review and network meta-analysis of randomized controlled trials
Hsien‐Yi Chiu, Yi‐Teng Hung, Yu‐Huei Huang
Therapeutic Advances in Chronic Disease (2023) Vol. 14
Open Access | Times Cited: 4
Bimekizumab in refractory pityriasis rubra pilaris
Christian Kromer, Michael P. Schön, Rotraut Mößner
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2023) Vol. 22, Iss. 1, pp. 102-104
Open Access | Times Cited: 4
Comparation of time-course, dose-effect, influencing factors and adverse events of biologics in the treatment of adults with moderate to severe plaque psoriasis
Weiqi Gao, Boran Yu, Ya Yan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Evolution of characteristics and biologic treatment effectiveness in patients of the Austrian psoriasis registry from 2004–2022
Thomas Graier, Wolfgang Salmhofer, Constanze Jonak, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2023) Vol. 21, Iss. 12, pp. 1513-1523
Open Access | Times Cited: 2
The seroconversion rate of QuantiFERON-TB gold in-tube test in psoriatic patients receiving anti-interleukin-23 monoclonal antibodies
Yi‐Wei Huang, Tsen‐Fang Tsai
Dermatologica Sinica (2022) Vol. 40, Iss. 2, pp. 94-99
Open Access | Times Cited: 4
Bimekizumab bei refraktärer Pityriasis rubra pilaris
Christian Kromer, Michael P. Schön, Rotraut Mößner
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 1, pp. 102-105
Open Access
Entwicklung der Patientencharakteristika und der Wirksamkeit der Biologika‐Therapie bei Patienten des Österreichischen Psoriasis‐Registers von 2004 bis 2022
Thomas Graier, Wolfgang Salmhofer, Constanze Jonak, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2023) Vol. 21, Iss. 12, pp. 1513-1523
Open Access | Times Cited: 1
Newer Biologics for the Treatment of Plaque Psoriasis
Anusree Subramonian, Melissa Walter
Canadian Journal of Health Technologies (2021) Vol. 1, Iss. 9
Open Access | Times Cited: 3
Coverage of Specialty Drugs for Psoriasis and Psoriatic Arthritis by Commercial Insurance Companies
Christine Learned, Sara Alsukait, Kristin Fiumara, et al.
Journal of Psoriasis and Psoriatic Arthritis (2022) Vol. 7, Iss. 4, pp. 160-163
Open Access | Times Cited: 2
Bimekizumab (Bimzelx)
CADTH
Canadian Journal of Health Technologies (2022) Vol. 2, Iss. 5
Open Access | Times Cited: 1
Formulary Management of Biologics in Plaque Psoriasis
Chris Vannabouathong, Peter Dyrda
Canadian Journal of Health Technologies (2023) Vol. 3, Iss. 3
Open Access
Ekzematisierte Psoriasis – eine häufige, aber oft vernachlässigte Variante der Plaque‐Psoriasis
Felix Lauffer, Kilian Eyerich
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2023) Vol. 21, Iss. 5, pp. 445-454
Open Access
Page 1

Scroll to top